Tag: noTitle
-
We Need You to Volunteer!
A letter from the Medical Alumni Association Board (MAAB) president.
-
Ahead of the Curve
In a remarkable place such as ours – a medical school designed for continuous learning, innovation, and discovery — looking ahead is central to our mission. The students we train today will advance to become leaders of the future; the knowledge we uncover here and now can develop into treatments and cures for generations to come.
-
Feinberg Among Top Medical Schools
Feinberg has been recognized as one of the best medical schools in the nation, ranking 17th among research-oriented institutions, by U.S. News & World Report.
-
Celebrating Match Day 2022
On Match Day, fourth-year medical students celebrated their success as they learned where they will spend the next three to seven years as residents.
-
Faculty Awards & Honors
Learn about the recent achievements of Feinberg School of Medicine faculty and leaders.
-
Genetic Variant of High-risk Childhood Leukemia Revealed
A genetic mutation changing just one base pair of nucleotides greatly increases risk of a lethal subtype of childhood acute lymphoblastic leukemia.
-
Investigating Prevalence Risk of Familial Heart Failure
Idiopathic dilated cardiomyopathy (DCM) was found to have a familial etiology in 30 percent of individuals diagnosed with DCM.
-
New Treatment for Metastatic Hormone-Sensitive Prostate Cancer
The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.
-
Neural Stem Cell Therapy May Improve Metastatic Cancer Survival
Neural stem cells used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2 positive breast cancer brain metastases.
-
On the Cusp
David Holtzman, ’85 MD, is breaking new ground in identifying, treating, and preventing Alzheimer’s disease and other disorders that affect memory and thinking.